RIGEL PHARMACEUTICALS, INC. (RIGL) Gross margin 2018–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) gross margin by fiscal year — reported gross profit divided by reported revenue.
93.3%FY2025 · since FY2018: 99.4% → 93.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 93.3% | +3.7 pp |
| FY2024 | 89.6% | -4.3 pp |
| FY2023 | 93.9% | -4.6 pp |
| FY2022 | 98.5% | -0.7 pp |
| FY2021 | 99.3% | +0.1 pp |
| FY2020 | 99.2% | +0.7 pp |
| FY2019 | 98.5% | -0.9 pp |
| FY2018 | 99.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice